Poseida Therapeutics, Inc. PSTX
9.50 0.00 (+0.00%)
At closeJan 7, 2025, 4:00 PM EST
9.50 Day range 9.58
52-week range unavailable
- YTD
- -1.04%
- 1 year
- +178.59%
Analyst view
Consensus: hold
Hold
Price target (mean) 9.50 0.0% upside
Now 9.50
- Target (low)
- 9.00
- Target (mean)
- 9.50
- Target (high)
- 10.00
Ratings (0m) 5 0 buy · 5 hold · 0 sell
- Strong buy0
- Buy0
- Hold5
- Sell0
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 5
- 2 months ago 5
- 3 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.35667 | -0.50 – -0.28 | -0.27 | -32.1% | 21.25M | -15.0% | 3 |
| Next quarter | -0.46667 | -0.65 – -0.29 | -0.25 | -86.7% | 7.50M | -73.4% | 3 |
| Current year | -0.72667 | -0.87 – -0.65 | -1.37 | +47.0% | 147.11M | +127.4% | 3 |
| Next year | -1.80 | -2.10 – -1.29 | -0.72667 | -148.2% | 43.33M | -70.5% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 26, 2024 | BTIG | Downgrade | Buy | Neutral |
| Nov 26, 2024 | William Blair | Downgrade | Outperform | Market Perform |
| Nov 26, 2024 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Nov 15, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 8, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 30, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 17, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 6, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 25, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 22, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 2, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 22, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 8, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Dec 11, 2023 | Piper Sandler | Maintained | Overweight | Overweight |
| Dec 11, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Oct 10, 2023 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Aug 8, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 23, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 10, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Mar 10, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Feb 23, 2023 | HC Wainwright & Co. | Maintained | — | Buy |
| Feb 1, 2023 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Jan 4, 2023 | HC Wainwright & Co. | Initiated | — | Buy |
| Aug 9, 2022 | Piper Sandler | Maintained | — | Overweight |
| May 13, 2022 | Piper Sandler | Maintained | — | Overweight |
| Jan 7, 2022 | Cantor Fitzgerald | Initiated | — | Overweight |
| May 18, 2021 | BTIG | Initiated | — | Buy |
| Aug 4, 2020 | B of A Securities | Initiated | — | Buy |
| Aug 4, 2020 | Piper Sandler | Initiated | — | Overweight |